Table 1.
Key clinical timeline of this case
| Date | Key Clinical Process |
|---|---|
| 2017/9 | Diagnosis of EBV-associated T-cell lymphoproliferative disease |
| 2023/12 | Cervical lymphadenopathy for 4 d, fever for 3 d |
| 2023/12 | Diagnosis of CAEBV, T-cell type, grade 1-2 |
| 2023/12-2024/3 | Prednisone and etoposide chemotherapy, EBV-PCR <500 |
| 2024/3/11 | Peripheral blood stem cell infusion |
| 2024/3/12 | Donor lymphocyte infusion-related rash |
| 2024/3/13 | Sepsis |
| 2024/3/25 | Engraftment syndrome |
| 2024/3/27 | Grade 3 skin GVHD |
| 2024/4/9 | Hyponatremic seizures, hypertensive encephalopathy |
| 2024/4/12 | Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) |